CLASS II Device recall · Reported 16 Feb 2022 · FDA Enforcement Report

Attune Revision Distal Femoral Augment SZ 6- Intended as recalled

DePuy Orthopaedics is recalling Attune Revision Distal Femoral Augment SZ 6- Intended as a Component in total knee, distributed nationwide in the US. The recall was initiated on 5 Jan 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: JJ3389 GTIN: 10603295382775
Quantity recalled3 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0632-2022
FDA event ID
89454
Recalling firm
DePuy Orthopaedics, Warsaw, IN
Classification
Class II
Status
Terminated
Recall initiated
5 Jan 2022
FDA classified
9 Feb 2022
Reported
16 Feb 2022
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

5 Jan 2022Recall initiated by company
9 Feb 2022Classified by FDA+35 days
16 Feb 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.

Product as listed by the FDA

ATTUNE REVISION DISTAL FEMORAL AUGMENT SZ 6 4MM- Intended as a Component in total knee arthroplasty (TKA) revision surgeries Product Number: 154706001

Where it was distributed

US Nationwide distribution in the states of TN, TX.

Nationwide TennesseeTexas

Questions about this recall

Why was it recalled?

May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.

Which lots are affected?

Lots: JJ3389 GTIN: 10603295382775

Where was it sold?

US Nationwide distribution in the states of TN, TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 89454

This product is part of a recall event; the main page for the event is Attune Revision Posterior Femoral Augment SZ 9-intended as recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIAttune Revision Posterior Femoral Augment SZ 9-intended as recalledDePuy OrthopaedicsOtherNationwide

More recalls from DePuy Orthopaedics

All 153

Other Hip & Knee Implants recalls

All 3,097